semaglutide and kidney Semaglutides Are Poised to Remake Chronic Disease Care Semaglutide in chronic kidney disease

It's like some magical switch went off that completely erased my obsession with food

The increasingly popular obesity and diabetes drugs known as glucagon-like peptide-1 receptor agonists do not seem to worsen suicidality despite previous concerns, according to recent data published in BMJ.Case reports that linked GLP-1s to suicidality have raised regulatory concerns and left many wondering if these medications are harming the patients they intend to help, Laurent Azoulay, PhD, a

Heres how the program works, whats included, and who may qualify.

It was edited by Marianne McCune, fact-checked by Sierra Juarez, and engineered by Gilly Moon and Debbie Daughtry

Reach your weight-loss goals with physician-guided care in Honolulu

The findings highlight an important message: obesity is a chronic condition that often requires personalized, long-term management